Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Koru Medical Systems Inc
(NQ:
KRMD
)
2.340
-0.010 (-0.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Koru Medical Systems Inc
< Previous
1
2
3
Next >
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance
August 07, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
July 25, 2024
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda
July 24, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024
July 17, 2024
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
July 02, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
June 05, 2024
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
June 04, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
May 14, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
May 01, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
April 17, 2024
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
April 11, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
March 18, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
March 13, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
March 11, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
March 06, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
February 21, 2024
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference
November 29, 2023
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023
November 28, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System
November 08, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
November 08, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook
November 08, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes
November 07, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Participate in Upcoming Investor Conferences
November 02, 2023
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023
October 25, 2023
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference
October 05, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors
October 04, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase
September 15, 2023
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook
August 09, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference
August 08, 2023
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates
August 02, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.